Hipod 100 Oral Suspension contains Cefpodoxime Proxetil 100 mg, a third-generation cephalosporin antibiotic with broad-spectrum activity against Gram-positive and Gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and otitis media. Cefpodoxime Proxetil acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The oral suspension formulation facilitates ease of administration, particularly in pediatric and geriatric patients who may have difficulty swallowing tablets. Hipod 100 is absorbed rapidly from the gastrointestinal tract and converted to the active metabolite cefpodoxime, achieving effective plasma concentrations. It is generally well tolerated, with common adverse effects including gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Hypersensitivity reactions may occur in patients with a history of penicillin or cephalosporin allergy. Dosage should be adjusted based on the severity of infection, patient age, and renal function. It is essential to complete the full prescribed course to prevent the development of resistance. Hipod 100 Oral Suspension should be stored at controlled room temperature and protected from light. Use under medical supervision is recommended to ensure appropriate therapy and monitoring.